Evidence Hub

Application of the Formula for Rational Antimicrobial Therapy (FRAT) toCommunity-Acquired Pneumonia

J. Blondeau, N. Theriault

2017

3 citations

Abstract

Community-acquired pneumonia (CAP) remains a common condition for which patients seek medical advice in

the outpatient setting and where antimicrobial agents are prescribed empirically–often based on therapeutic

guideline recommendations. Antimicrobial resistance impacts on therapeutic choices as resistance is associated

with clinical failure which in turn may impact morbidity and mortality. The Formal for Rational Antimicrobial Therapy (FRAT) considers etiology and antimicrobial susceptibility to generate a factor to predict the likely activity of an

antimicrobial agent in CAP or any other infection for which etiology and susceptibility data can be considered. In

considering the FRAT formula in CAP, amoxicillin and macrolides offer a predictability of 52.6-78.3% whereas for

trimethoprim/sulfamethoxazole the predictability was 45.2% as compared to 90.1% for tetracyclines/doxycycline and

98.2% for levofloxacin (and moxifloxacin) . The FRAT formula clearly differentiates antimicrobial agents based on

spectrum of activity and impact of antimicrobial resistance and provides yet another factor for consideration in the

selection of an antimicrobial agent for treatment of CAP.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free